AFP and hepatocellular carcinoma: Patients with recurrent HCC were of significantly younger median age (55 vs. 59 yrs., p = 0.0255) and had significantly higher median pre-treatment AFP levels (101.3 vs. 14.2 IU/mL, p = 0.0036).